HomeCompareINNMF vs VIG

INNMF vs VIG: Dividend Comparison 2026

INNMF yields 1081.08% · VIG yields 1.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 INNMF wins by $37306288.15M in total portfolio value
10 years
INNMF
INNMF
● Live price
1081.08%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37306288.18M
Annual income
$31,563,031,594,132.85
Full INNMF calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.64%
Share price
$210.70
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.4K
Annual income
$179.15
Full VIG calculator →

Portfolio growth — INNMF vs VIG

📍 INNMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodINNMFVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, INNMF + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
INNMF pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INNMF
Annual income on $10K today (after 15% tax)
$91,891.89/yr
After 10yr DRIP, annual income (after tax)
$26,828,576,855,012.92/yr
VIG
Annual income on $10K today (after 15% tax)
$139.33/yr
After 10yr DRIP, annual income (after tax)
$152.28/yr
At 15% tax rate, INNMF beats the other by $26,828,576,854,860.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INNMF + VIG for your $10,000?

INNMF: 50%VIG: 50%
100% VIG50/50100% INNMF
Portfolio after 10yr
$18653144.11M
Annual income
$15,781,515,797,156.00/yr
Blended yield
84.61%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INNMF buys
0
VIG buys
0
No recent congressional trades found for INNMF or VIG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricINNMFVIG
Forward yield1081.08%1.64%
Annual dividend / share$2.00$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$37306288.18M$32.4K
Annual income after 10y$31,563,031,594,132.85$179.15
Total dividends collected$36872092.59M$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: INNMF vs VIG ($10,000, DRIP)

YearINNMF PortfolioINNMF Income/yrVIG PortfolioVIG Income/yrGap
1← crossover$118,808$108,108.11$11,304$163.92+$107.5KINNMF
2$1,327,510$1,200,385.03$12,759$166.33+$1.31MINNMF
3$13,955,553$12,535,117.70$14,382$168.52+$13.94MINNMF
4$138,087,992$123,155,549.73$16,192$170.52+$138.07MINNMF
5$1,286,637,044$1,138,882,892.71$18,210$172.34+$1286.62MINNMF
6$11,294,046,827$9,917,345,190.59$20,460$173.98+$11294.03MINNMF
7$93,443,552,038$81,358,921,932.82$22,968$175.48+$93443.53MINNMF
8$729,086,740,275$629,102,139,594.15$25,763$176.83+$729086.71MINNMF
9$5,367,529,524,068$4,587,406,711,974.06$28,878$178.05+$5367529.50MINNMF
10$37,306,288,184,886$31,563,031,594,132.85$32,350$179.15+$37306288.15MINNMF

INNMF vs VIG: Complete Analysis 2026

INNMFStock

Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for oncology and chronic fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other cancers and fibrotic diseases indications, that has completed Phase I clinical trial; and AMP886 for cancer and fibrotic disease indication. It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

Full INNMF Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this INNMF vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INNMF vs SCHDINNMF vs JEPIINNMF vs OINNMF vs KOINNMF vs MAININNMF vs DGROINNMF vs NOBLINNMF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.